Ignite Creation Date:
2024-05-06 @ 12:44 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01640444
Status:
COMPLETED
Last Update Posted:
2019-04-11
First Post:
2012-06-13
Brief Title:
Influence of BRAF and PIK3K Status on the Efficacy of 5-FluorouracilLeucovorinOxaliplatin FOLFIRI Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and 3 Circulating Tumor Cells CTC
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD